Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species

By Choo E. F.   Driscoll J. P.   Feng J.   Liederer B.   Plise E.   Randolph N.   Shin Y.   Wong S.   Ran Y.  

Xenobiotica, Vol. 39, Iss. 9, 2009-09 ,pp. : 700-709

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor α agonist in preclinical species and human

By Frederick K.S.   Maurer T.S.   Kalgutkar A.S.   Royer L.J.   Francone O.L.   Winter S.M.   Terra S.G.   Chen D.   Gao X.  

Xenobiotica, Vol. 39, Iss. 10, 2009-10 ,pp. : 766-781

Informa Healthcare

Access to resources Recommend Favorite

Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition

By Bleasby* K.   Castle* J. C.   Roberts C. J.   Cheng C.   Bailey W. J.   Sina J. F.   Kulkarni A. V.   Hafey M. J.   Evers R.   Johnson J. M.   Ulrich R. G.   Slatter J. G.  

Xenobiotica, Vol. 36, Iss. 10-11, 2006-10 ,pp. : 963-988

Informa Healthcare

Access to resources Recommend Favorite

Preclinical disposition and pharmacokinetics-pharmacodynamic modeling of biomarker response and tumour growth inhibition in xenograft mouse models of G-573, a MEK inhibitor

By Choo Edna F.   Belvin Marcia   Chan Jocelyn   Hoeflich Klaus   Orr Christine   Robarge Kirk   Yang Xiaoye   Zak Mark   Boggs Jason  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 751-762

Informa Healthcare

Access to resources Recommend Favorite

Disposition of LY333531, a selective protein kinase C β inhibitor, in the Fischer 344 rat and beagle dog

By Burkey J. L.   Campanale K. M.   O'Bannon D. D.   Cramer J. W.   Farid N. A.  

Xenobiotica, Vol. 32, Iss. 11, 2002-11 ,pp. : 1045-1052

Informa Healthcare

Access to resources Recommend Favorite